B-AEA
B-AEA (MM22) is a biotinylated endocannabinoid analog with probe activity. b-AEA is able to accumulate intracellularly in a similar manner to the parent compound AEA. b-AEA does not interact with other components of the endocannabinoid system and therefore does not interfere with their function. b-AEA can be used to visualize the accumulation and intracellular distribution of endocannabinoids[1].
Product Specifications
CAS Number
956605-71-3
Product Name Alternative
MM22; Biotinylated N-arachidonoylethanolamine
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/b-aea.html
Purity
95.89
Solubility
DMSO : 87.5 mg/mL (ultrasonic)
Smiles
O=C(NCCOCCOCCNC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O
Molecular Formula
C36H60N4O5S
Molecular Weight
660.95
References & Citations
[1]Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R), CF488A conjugate, 0.1mg/mL
Recombinant Human CD19/Leu-12 Protein (His Tag)
Recombinant Human CD19/Leu-12 Protein (His Tag)
